Mammography screening for breast cancer

New England Journal of Medicine

Volumn 367, Issue 21, 2012, Pages e31(1)-

  Smith, Robert A ^a   Kerlikowske, Karla ^b   Miglioretti, Diana L ^c,d   Kalager, Mette ^e,f,g  

^a AMERICAN CANCER SOCIETY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF OSLO   (Norway)

^f Telemark Hospital   (Norway)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ANAMNESIS; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CASE REPORT; CAUSE OF DEATH; DIAGNOSTIC TEST; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; MAMMOGRAPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION;

EID: 84869422628     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMclde1212888     Document Type: Article

References (25)

1. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012;367:1998-2005.
2. Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010;363:1203-10.
3. Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer 2011;117:714-22.
4. Moss SM, Nyström L, Jonsson FH, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies. J Med Screen 2012;19:26-32.
5. Njor S, Nyström L, Moss S, et al. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med Screen 2012;19:33-41.
6. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151:716-26. [Errata, Ann Intern Med 2010;152:199-200, 688.]
7. Wu LC, Grabaud BI, Gail MH. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years. Ann Intern Med 2012;157:597.
8. Shapiro S, Venet W, Strax P, Venet L. Periodic screening for breast cancer: the Health Insurance Plan Project and its sequelae. Baltimore: Johns Hopkins University Press, 1988.
9. Tabar L, Vitak B, Yen MF, Chen HH, Smith RA, Duffy SW. Number needed to screen: lives saved over 20 years of follow-up in mammographic screening. J Med Screen 2004;11:126-9.
10. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med 2011;155:481-92.
11. Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG. US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ 2000;320:1635-40.
12. Puliti D, Duffey SW, Miccinesi G, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 2012;19:42-56.
13. Malmgren JA, Parikh VP, Attwood MK, Kaplan HG. Impact of mammography detection on the course of breast cancer in women aged 40-49 years. Radiology 2012;262:797-806.
14. Sasieni PD. Outcomes of screening to prevent cancer: think of screening as insurance. BMJ 2003;327:50.
15. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:727-37.
16. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 2009;151:738-47. [Erratum, Ann Intern Med 2010;152:136.]
17. Kerlikowske K, Cook A, Buist DSM, et al. Breast cancer risk by breast density, age, menopause, and postmenopausal hormone therapy use. J Clin Oncol 2010;28:3830-7.
18. Kerlikowske K, Walker R, Miglioretti DL, Desai A, Ballard- Barbash R, Buist DSM. Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst 2008;100:1724-33.
19. Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med 2011;155:10-20.
20. van Ravesteyn NT, Miglioretti DL, Stout NK, et al. What level of risk tips the balance of benefits and harms to favor screening mammography starting at age 40? Ann Intern Med 2012;156:609-17.
21. Surveillance, Epidemiology, and End Results (SEER). The risk of developing/dying from cancer based on the November 2011 SEER submission. Bethesda, MD: National Cancer Institute (http://seer.cancer.gov/faststats).
22. Rothwell PM, Fowkes FGR, Belch JFF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long term risk of death due to cancer: analysis of individual patient data from randomised trails. Lancet 2011;377:31-41.
23. Vandvik PO, Lincoff M, Gore JM, et al. Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;141:Suppl:e637S-e668S. [Erratum, Chest 2012;141:1129.]
24. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 2011;343:d4411.
25. Jørgensen KJ, Zahl PH, Gøtzsche P. Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ 2010;340:c1241.